Beneficial effects of the vasopeptidase inhibitor omapatrilat on neurogenic volume retention in rats with experimental congestive heart failure (CHF)

被引：0
|
作者：
Klanke, B [1 ]
Karl, HF [1 ]
Ditting, T [1 ]
Schmieder, RE [1 ]
Veelken, R [1 ]
机构：
[1] Univ Erlangen Nurnberg, Erlangen, Germany
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2002年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：512A / 512A
页数：1
相关论文
共 50 条
  • [21] Beneficial renal and hemodynamic effects of omapatrilat in mild and severe heart failure
    Troughton, RW
    Rademaker, MT
    Powell, JD
    Yandle, TG
    Espiner, EA
    Frampton, CM
    Nicholls, MG
    Richards, AM
    HYPERTENSION, 2000, 36 (04) : 523 - 530
  • [22] Vasopeptidase Inhibitor,Omapatrilat, Enhances Cardiac Positive Inotropic and Lusitropic Responses to Dobutamine and Exercise in Heart Failure: Assessment by Pressure-Volume Analysis
    Hasegawa, Hiroshi
    Cheng, Heng-Jie
    Morimoto, Atsushi
    Little, William C.
    Cheng, Che Ping
    CIRCULATION, 2013, 128 (22)
  • [23] ROLE FOR VASOPRESSIN (AVP) IN RATS WITH CONGESTIVE HEART-FAILURE (CHF)
    YARED, A
    KON, V
    BRENNER, BM
    ICHIKAWA, I
    KIDNEY INTERNATIONAL, 1985, 27 (01) : 337 - 337
  • [24] Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial
    Rouleau, JL
    Pfeffer, MA
    Stewart, DJ
    Isaac, D
    Sestier, F
    Kerut, EK
    Porter, CB
    Proulx, G
    Qian, CL
    Block, AJ
    LANCET, 2000, 356 (9230): : 615 - 620
  • [25] Beneficial effects of sampatrilat, a novel vasopeptidase inhibitor, on cardiac remodeling and function of rats with chronic heart failure following left coronary artery ligation
    Maki, T
    Nasa, Y
    Tanonaka, K
    Takahashi, M
    Takeo, S
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 305 (01): : 97 - 105
  • [26] Vasopeptidase inhibition with omapatrilat in chronic heart failure: Acute and long-term hemodynamic and neurohumoral effects
    McClean, DR
    Ikram, H
    Mehta, S
    Heywood, JT
    Rousseau, MF
    Niederman, AL
    Sequeira, RF
    Fleck, E
    Singh, SN
    Coutu, B
    Hanrath, P
    Komajda, M
    Bryson, CC
    Qian, CL
    Hanyok, JJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (12) : 2034 - 2041
  • [27] BENEFICIAL-EFFECTS OF TRANDOLAPRIL ON EXPERIMENTALLY INDUCED CONGESTIVE-HEART-FAILURE IN RATS
    FORNES, P
    RICHER, C
    PUSSARD, E
    HEUDES, D
    DOMERGUE, V
    GIUDICELLI, JF
    AMERICAN JOURNAL OF CARDIOLOGY, 1992, 70 (12): : D43 - D51
  • [28] EXPERIMENTAL CONGESTIVE HEART-FAILURE IN RATS
    JOUANNOT, P
    COURTALON, A
    GOURDIER, B
    HATT, PY
    PATHOLOGIE BIOLOGIE, 1973, 21 (06): : 623 - 627
  • [29] Natriuretic peptides in chronic stable heart failure patients treated with omapatrilat, a vasopeptidase inhibitor: The IMPRESS neurohormone substudy.
    Sheth, T
    Parker, T
    Block, A
    Qian, CL
    Rouleau, J
    CIRCULATION, 2001, 104 (17) : 762 - 762
  • [30] BENEFICIAL EFFECT OF ACE-INHIBITOR IN CONGESTIVE-HEART-FAILURE
    TAKEDA, N
    TANAMURA, A
    IWAI, T
    KATO, M
    NOMA, K
    NAGANO, M
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 1993, 129 (02) : 139 - 143
12345